Video

What Kids Wear Could Determine How Much Exercise They Get

Few College Students Have Received the H1N1 Vaccine

Night Lights Could Lead to Depression

Cervarix Has Been Approved by the FDA

The FDA Is Studying the Effects of Lasik Surgery

Painkillers Can Dull the Effects of Childhood Vaccines

Childbirth May Becoming More Complicated

Botox Sponges Might Help Nose Allergies

The FDA Advises on How to Properly Dispose of Medicine

A French Study Shows Cell Phones Do Not Affect Humans

MRIs May Lead to More Back Surgery

Your More Likely to Wash Your Hands If Someone's Watching

Co-Sleeping Is a Leading Cause of SIDS

Night Shifts Don't Have a Major Effect On Surgeons

Exercise May Counter Fatigue from Chemotherapy

Combination Therapy Best for Aggressive Prostate Cancer

Posted on 07/14/2009, 06:00
By -- Robert Preidt

Adding radiation and hormone treatment to brachytherapy improves survival, study shows

MONDAY, July 13 (HealthDay News) -- Men with aggressive prostate cancer who have brachytherapy alone are more likely to die than those who receive a combination of treatments, new findings show.

In brachytherapy, radioactive "seeds" are implanted in the tumor.

"Despite the increasing numbers of men worldwide who choose to undergo brachytherapy alone for their high-risk prostate cancer, the evidence supporting this treatment method alone based on survival data from randomized trials is lacking," lead researcher Dr. Anthony D'Amico, chief of genitourinary radiation oncology at Brigham and Women's Hospital in Boston, said in a news release from the hospital.

"In order to get the highest cure rate for men with high-risk prostate cancer, it appears that five weeks of external beam radiation and at least four months of hormonal therapy should be added to brachytherapy," he added.

D'Amico and his colleagues studied death rates from prostate cancer in 1,342 patients with high-risk cancer and at least a 10-year life expectancy. The men were treated using brachytherapy alone or in combination with hormone therapy (androgen-suppression therapy), external beam radiation therapy, or both, according to the study, which appears online and in an upcoming print issue of the Journal of Clinical Oncology.

Despite a higher baseline risk of death from prostate cancer, patients who had a combination of brachytherapy, hormone therapy and external beam radiation therapy had a lower risk of death from prostate cancer after treatment than those who received brachytherapy alone, brachytherapy and external beam radiation, or brachytherapy and hormone therapy.

More information

The U.S. National Cancer Institute has more about prostate cancer treatment.

SOURCE: Brigham and Women's Hospital, news release, July 13, 2009

More news in Prostate Health...

BigHealthTree.com Disclaimer

Bighealthtree.com Does Not Provide Medical Advice. This site, including the above information, is for informational purposes only and is not a substitute for professional medical or health advice. Always seek the advice of your physician or a qualified health or medical professional before starting any new treatment, changing existing treatment, or altering your current exercise and/or diet program. If you think you are having a medical emergency, call 911 (or the emergency services in your area) or your doctor immediately.

Rating: 3.2 / 5 (56 votes)